Alternatives to Compass Pathways
Compass Pathways is a Biotechnology tool: accelerating patient access to evidence-based innovation in mental health. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Compass Pathways
Red Light Holland .Not ratedCanadian company operating in the legal psilocybin industry, focusing on cultivation, production, and distribution of psilocybin products.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Precision BioSciencesNot ratedA clinical-stage biotechnology company developing in vivo gene editing therapies.
Rocket PharmaceuticalsNot ratedA biotechnology company developing genetic therapies for rare disorders.
Showing the next 20 closest matches. See the rest on the Compass Pathways profile.
Sponsored rows are paid and labelled. Advertise on this page
